Editas Medicine Return on Net Operating Assets Trends

Editas Medicine, Inc. (EDIT)

2.14 +0.03 (+1.42%) USD | NASDAQ | Feb 25, 13:24

View Return on Net Operating Assets for EDIT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Biogen, Inc.	Upgrade
ADMA Biologics, Inc.	Upgrade
Arcutis Biotherapeutics, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade

Return on Equity	Upgrade
Return on Assets	Upgrade
Return on Invested Capital	Upgrade
Profit Margin (Quarterly)	Upgrade
Gross Profit Margin (Quarterly)	Upgrade
Operating Margin (Quarterly)	Upgrade